(Q31026806)

28 June 2017

1 reference

title

The diagnosis of Parkinson's disease (English)

1 reference

28 June 2017

0 references

3

Werner Poewe

1 reference

28 June 2017

2

Gregor Wenning

1 reference

28 June 2017

1

Eduardo Tolosa

1 reference

28 June 2017

1 January 2006

1 reference

28 June 2017

1 reference

28 June 2017

5

1 reference

28 June 2017

75-86

1 reference

28 June 2017

1

1 reference

Diagnostic criteria for Parkinson disease

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The evolution of diagnosis in early Parkinson disease. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Accuracy of clinical diagnosis of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

How valid is the clinical diagnosis of Parkinson's disease in the community?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Accuracy of diagnosis in patients with presumed Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Clinical correlates of action tremor in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Re-emergent tremor of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Clinical characteristics of essential tremor: data from a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Parkinsonism in Patients with Lacunar Infarcts of the Basal Ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Lower body parkinsonism: evidence for vascular etiology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Parkinsonism and basal ganglia infarcts.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Clinical correlates of vascular parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

MRI in patients with suspected vascular parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Olfactory function distinguishes vascular parkinsonism from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Risk of dementia in Parkinson's disease: a community-based, prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

A Population-Based Investigation of Parkinson's Disease With and Without Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Fluctuations in attention: PD dementia vs DLB with parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Progressive supranuclear palsy: clinical and pathological diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Update on epidemiological aspects of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Retrospective study of drug response in 87 patients with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The definition of multiple system atrophy: a review of recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

"Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The dopaminergic response in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Corticobasal degeneration. A clinical study of 36 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Dementia as the most common presentation of cortical-basal ganglionic degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Clinical presentation and pharmacological therapy in corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Drug-induced parkinsonism in a movement disorders unit: A four-year survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Coexistent tardive dyskinesia and parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

DAT imaging in drug-induced and psychogenic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Clinicopathological study of 35 cases of multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Unraveling the pathogenesis of Parkinson's disease--the contribution of monogenic forms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Association between early-onset Parkinson's disease and mutations in the parkin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Challenge tests to predict the dopaminergic response in untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The symptomatic treatment of multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The L-dopa response in vascular parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Increase of the Bereitschaftspotential in simultaneous and sequential movements.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Evidence for abnormal long-loop reflexes in rigid Parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Sympathetic skin response and R-R interval variability in multiple system atrophy and idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The auditory startle reaction in parkinsonian disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Striated anal sphincter denervation in patients with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Eye movements in parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Olfaction and Parkinson's syndromes: its role in differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Olfactory function in atypical parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

3-OMD and homocysteine plasma levels in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Basal ganglia lacunes and parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Differentiation of atypical parkinsonian syndromes with routine MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Clinical and [18F] dopa PET findings in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Perspectives of B-mode transcranial ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970285-4

7 January 2021

10.1016/S1474-4422(05)70285-4

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

16361025